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ABSTRACT Telomerase activity was identified in extracts
from several different mouse cell lines. Addition of telomeric
TTAGGG repeats was specific to telomeric oligonucleotide
primers and sensitive to pretreatment with RNase A. In
contrast to the hundreds of repeats synthesized by the human
and Tetrahymena telomerase enzymes in vitro, mouse telo-
merase synthesized only one or two TTAGGG repeats onto
telomeric primers. The products observed after elongation of
primers with circularly permuted (TTAGGG)3 sequences and
after chain termination with ddATP or ddTTP indicated that
mouse telomerase pauses after the addition of the first dG
residue in the sequence TTAGGG. The short length of the
products synthesized by mouse telomerase was not due to a
diffusible inhibitor in the mouse extract, because the human
telomerase continued to synthesize long products when mixed
with mouse fractions. Primer challenge experiments showed
that the human enzyme synthesized long TTAGGG repeats
processively in vitro, whereas the mouse telomerase appeared
to be much less processive. The identification of short telo-
merase reaction products in mouse extracts suggests that
extracts from other organisms may also generate only short
products. This knowledge may aid in the identification of
telomerase activity in organisms where activity has not yet been
detected.
Telomerase is a highly specialized DNA polymerase which
synthesizes telomeric repeat sequences de novo both in vitro
and in vivo (reviewed in ref. 1). Net telomere elongation by
telomerase may balance the loss of sequences from chromo-
some ends at each round of DNA replication (2, 3). Telo-
merase is a ribonucleoprotein in which the RNA component
provides the template for the synthesis of telomeric repeats
(4, 5). Telomerase activity has been identified in the ciliates
Tetrahymena, Euplotes, and Oxytricha and in transformed
human cells (for review see refs. 1 and 6). In vitro, Tetrahy-
mena telomerase is highly processive, synthesizing hundreds
of telomeric (TTGGGG)n repeats (7). Telomere lengthening
in Tetrahymena in vivo appears to be much less processive
than primer elongation by telomerase in vitro (8), suggesting
that telomere length could be regulated in part by telomerase
processivity. The large number of yeast genes which affect
telomere length (9-13) suggest that length regulation may be
a complex process involving telomerase, telomere-binding
proteins, and other components.
Telomere length regulation is implicated in both cellular
senescence and the immortalization of human cells. In pri-
mary somatic cells, telomeric (TTAGGG)n repeats are lost
with age both in vivo and in vitro. This shortening has been
proposed to play a role in signaling the cell cycle exit
characteristic of senescent cells (14, 15), although a causal
role has not been demonstrated. In contrast to primary
human cells, telomere length in immortalized cell lines is
stably maintained (16, 17). Recent data (18) have shown that
telomerase activity was not detectable in primary human cells
when telomeres were shortening. However, immortalized
clones arising from simian virus 40 T-antigen-transformed
primary cells had both stable telomere length and detectable
telomerase activity. This suggests that activation of telo-
merase may be essential for the growth of immortalized
human cells.
To further explore the role of telomerase in cellular senes-
cence and immortalization, we have extended our studies of
telomere length and telomerase activity to mice. Mouse
telomeres consist of the same (TTAGGG)n repeated se-
quence found in humans, although the repeat tracts appear to
be much longer in Mus musculus than in human cells (19-21).
As an initial step in examining what role telomerase might
play in the generation and maintenance of the long telomere
tracts, we assayed for telomerase in mouse cell extracts and
characterized its activity.
MATERIALS AND METHODS
Cell Lines. FM3A cells were a gift from Carol Prives
(Columbia University, New York). NS-1 cells (P3/NS1/1-
Ag4-1; ATCC no. TIB 18) and the Jurkat cell line (ATCC no.
TIB 152) were obtained from the American Type Culture
Collection. The YAC-1 (ATCC no. TIB 160) and Sp2/0-Agl4
(ATCC no. CRL 1581) cell lines were gifts from Silvia
Bacchetti (McMaster University, Hamilton, ON, Canada).
Cell Extracts. S-100 extracts were prepared according to
the human S-100 protocol (18) and then were fractionated on
DEAE-agarose columns. Generally, a 1-ml DEAE-agarose
column was equilibrated with 0.1 M NaCI in "hypobuffer"
[24 mM Hepes, pH 8.0/7 mM KCI/2.4 mM MgCl2/1 mM
dithiothreitol/0.1 mM phenylmethanesulfonyl fluoride/1 gM
leupeptin/10,uM pepstatin A containing RNase inhibitor
(RNasin, 10 units/ml; Promega)], and a 1-ml aliquot of S-100
extract was loaded. The column was washed with 3 volumes
of 0.1 M NaCI in hypobuffer, and bound material was eluted
in steps with 2 volumes of0.2M NaCI in hypobuffer followed
by 2 volumes of 0.3 M NaCl in hypobuffer.
Telomerase Assay. An aliquot (20 ,ul) from each S-100 or
DEAE fraction was mixed with 20 ,ul of 2x reaction buffer
(100 mM Tris acetate, pH 8.5/100 mM potassium acetate/4
mM dTTP/4 mM dATP/2 mM MgCl2/2 mM spermidine/2
mM EGTA/10 mM 2-mercaptoethanol), 20 gCi of[a-32P]dGTP (800 Ci/mmol; NEN; 1 Ci = 37 GBq), and 1-2
,uM (TTAGGG)3 primer and incubated at 30°C for 60 min.
The reactions were stopped with 10mM EDTA in 5 mM Tris
(pH 7.5), and the samples were treated first with RNase A
(100,ug/ml) for 15 min at 37°C and then with proteinase K
(100 ,ug/ml) in 0.18% SDS/10 mM Tris (pH 7.5) for 15 min at
37°C and were extracted with phenol. The DNA products
were precipitated with ethanol and S ,g of tRNA and
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separated in an 8% acrylamide/7 M urea denaturing gel as
described (18).
Primer Challenge. S-100 extract was prepared from the cell
line 293 as described (18), and 110 /l of extract was prein-
cubated with an equal volume of 2 x reaction buffer (100 mM
Tris acetate, pH 8.5/100 mM potassium acetate/4 mM
dTTP/4 mM dATP/2 mM MgCl2/2 mM spermidine/10 mM
2-mercaptoethanol) and 1 MM (TTAGGG)3 primer for 3 min
at room temperature to allow binding ofprimer to telomerase.
At time zero 97 A.l of [a-32P]dGTP (970 ACi; 800 Ci/mmol;
NEN) was added to the preincubation mixture to give a final
concentration of 3.8 MM. After incubation at 30'C for 3 min,
110 ul of the reaction mixture was diluted 30-fold into 3.19 ml
of 1x reaction buffer (prewarmed to 300C) containing a final
concentration of 17 MM dGTP and either 2 MM (TTAGGG)3
primer or no primer. The remainder of the reaction mixture
was not diluted. All reactions proceeded at 30°C, and 1-ml
aliquots were removed from the dilution mixtures at 9, 18,
and 36 min after reaction initiation (i.e., 6, 15, and 33 min after
dilution). The remaining undiluted mixture (34 ,l) was al-
lowed to react for a total of 36 min. Reactions were termi-
nated and the products were precipitated and electropho-
resed as described (18).
FM3A cell S-100 extracts were purified over a DEAE
column as described and a 200-,lI aliquot of the active fraction
was incubated with an equal volume of 2x reaction buffer (as
above) and 1 MM (GTTGGG)3 primer. The reaction was
preincubated for 2 min at room temperature, and at time zero
20 Al of [a-32P]dGTP (200 ,Ci; 800 Ci/mmol; NEN) was
added to give a final concentration of 0.62 AM. The reaction
mixture was incubated at 30°C for 3 min, and then 160 IlI
aliquots were diluted 10-fold into 1.44 ml of lx reaction
buffer (prewarmed to 30°C) containing 10 ,uM dGTP and
either 3.3 MM (GGGGTT)3 primer or no primer. Of the
remaining undiluted reaction mixture, 40 ,l was stopped
immediately and 40 Al was terminated at 120 min from time
zero. All reactions proceeded at 30°C and 400-Al aliquots
were removed from the dilution mixtures and terminated at
15, 30, 60, and 120 min from time zero. The reaction products
were extracted with phenol, precipitated, and electropho-
resed in an 8% polyacrylamide sequencing gel (18).
Miccrococcal Nuclease Digestion. A sample (50 /4) of 293
S-100 extract was incubated for 15 min at 30°C with 100 units
of micrococcal nuclease and 1 mM CaCl2. The reaction was
stopped by addition of EGTA to 2.5 mM, the mixture was
chilled, and MgCl2 was added to 2.5 mM. The reaction
mixture was split into three aliquots of 17/4, and one aliquot
was assayed without further treatment. To the remaining two
aliquots, 15 Al of FM3A DEAE fraction was added and
assayed with or without RNase pretreatment. As a control,
20 /4 of 293 S-100 extract was preincubated for 5 min with 1
mM CaC12 and 2.5 mM EGTA and then treated for 15 min at
30°C with 40 units of micrococcal nuclease. The reaction
mixture was chilled and brought up to 2.5 mM MgCl2, and 17
Al was assayed for telomerase activity.
RESULTS AND DISCUSSION
S-100 extracts from the immortalized mouse cell line FM3A
were prepared with conditions optimized for human telo-
merase (22). The crude S-100 extract was loaded onto a
DEAE-agarose column and eluted with several steps of
increasing NaCl concentration, and all samples were assayed
for telomerase activity (data not shown). Although a ladder
of TTAGGG repeats typical of human or Tetrahymena
telomerase products was not observed, one predominant
product band was observed above the position of the input
primer oligonucleotide. The synthesis of this band was both
dependent on input (TTAGGG)3 and sensitive to pretreat-
ment of the extract with RNase A (Fig. 1). Similar nuclease
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FIG. 1. Characterization of mouse telomerase. The 0.2 M NaCl
DEAE fraction from FM3A cells was assayed using different input
primer oligonucleotides. Reaction products are shown in pairs with-
out (-) or with (+) RNase A pretreatment, respectively. Lanes 1 and
2, U2 5'(GGCCGAGAAGCGAT); lanes 3 and 4, Comp 12
(AAATCTAGTGCTG); lanes 5 and 6, yeast (TGTGTGGGTGT-
GTGGGTG); lanes 7 and 8, Tetrahymena [(TTGGGG)3]; lanes 9 and
10, Arabidopsis [(TTTAGGG)31; lanes 11 and 12, vertebrate[(TTAGGG)3d; lanes 13 and 14, no input oligonucleotide. Position of
a 32P-labeled (TTAGGG)3 is indicated by an arrowhead.
sensitivity has been demonstrated with Tetrahymena and
other telomerase enzymes (3, 22-24). The product band,
however, was insensitive to RNase A. The mouse activity
was eluted in 0.2 M NaCl, similar to the elution of human
telomerase from a DEAE column (25), and this fraction was
used in all subsequent experiments. Optimal (TTAGGG)3
primer labeling was obtained with 1-2 MM primer and 2 mM
each dATP and dTTP, and the products continued to accu-
mulate up to 120 min (data not shown). Both the product
accumulation and the requirement of the mouse telomerase
for high concentrations of primer and nucleotides are similar
to features observed for human telomerase (22).
We tested the ability of mouse telomerase to extend both
telomeric and nontelomeric oligonucleotides. Incorporation
of [a-32P]dGTP onto the telomeric primers (TTAGGG)3,
(TTTAGGG)4, (TTGGGG)3, and (TGTGTGGG)2TG was
sensitive to pretreatment with RNase A. The two nontelo-
meric primers U2 5' and Comp 12 were not elongated in the
extract, and no products were generated in the absence of
oligonucleotide (Fig. 1). This shows that the addition of
nucleotides is dependent on the input of telomeric primers,
and indicates that these primers are recognized specifically
by telomerase.
All telomerase enzymes characterized to date can specif-
ically recognize the 3' end sequence of telomeric primer
oligonucleotides and add the correct next base in the telo-
meric repeat. Because telomerase always pauses during
nucleotide addition at the same position within a repeat,
different product patterns are generated by using primers
with different 3' ends (3, 22-24). To determine whether the
short products generated in the mouse extracts were synthe-
sized by telomerase, three different 18-base primer oligonu-
cleotides containing permutations of the sequence
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(TTAGGG)3 were used. The oligonucleotides (TTAGGG)3,
(GGGTTA)3, and (GTTAGG)3 primed the addition of spe-
cific, yet different-length products (Fig. 2). The product
primed by (TTAGGG)3 was four nucleotides longer than the
input primer, whereas the product primed by (GTTAGG)3
was five nucleotides longer and that primed by (GGGTTA)3
was only one nucleotide longer. The product length generated
with each primer suggested that the correct sequence was
added and that primer elongation stopped after the addition
of the first dG residue in the sequence TTAGG.
The incorporation of dideoxynucleotides was used to con-
firm the nucleotide sequence added onto telomeric primers.
In the absence of dideoxynucleotides, the primer (GT-
TAGG)3 was elongated by five nucleotides, expected to
represent the addition of GTTAG. Consistent with this
interpretation, the product was one nucleotide shorter when
ddATP was added to the reaction mixture. When ddTTP was
added, a three-nucleotide decrease in size was seen (Fig. 2).
These results indicate that the short products generated by
the addition activity in the mouse cell extracts are telomerase
elongation products. They further show that mouse telo-
merase pauses or stops preferentially after the addition of the
first dG residue in the sequence TTAGjGG. This is the same
position in the repeat as the strong pause seen with the human
enzyme (22) and analogous to the pausing after the addition
by the Tetrahymena enzyme of the first dG in the sequence
TTjGGG (7).
Telomerase isolated from the ciliates Tetrahymena, Eu-
plotes, and Oxytricha and from human cells can elongate
telomeric-sequence oligonucleotides from heterologous spe-
cies (3, 22-24). Similarly, the mouse telomerase elongated
Tetrahymena telomere primers, although these products
showed the addition of two or three repeats rather than a
singe repeat. The oligonucleotide (TTGGGG)3 showed prod-
uct bands of 4 or 10 added nucleotides, (GGGGTT)3 had
products of 2, 8, or 14 nucleotides, and (GTTGGG)3 had 4,
10, or 16 nucleotides added (Fig. 2). The ability of the mouse
enzyme to synthesize longer products with the (TTGGGG)3
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primers may be due to differences in the secondary and
tertiary structures of these oligonucleotides (26-29) or to
mismatching of the template and primer sequences.
To determine whether the short products synthesized in
the mouse extracts were specific to the cell lines used or to
species differences between human and mouse, we surveyed
a number ofdifferent established mouse and human cell lines.
In addition to FM3A, S-100 extracts were made from the
mouse cell lines NS-1, YAC-1, and Sp2/0-Agl4 (see Mate-
rials and Methods) and fractionated on DEAE-agarose col-
umns. The (TTAGGG)3-primed elongation products from all
of these mouse extracts were short, like those of the FM3A
extract described above (data not shown). Human telomerase
activity has been assayed in our laboratory and others from
at least five different cell lines: HeLa (22), 293, HAl, and
HL-60 (18), and Jurkat (data not shown, see Materials and
Methods). In each case the products were long, indicating
that many repeats were synthesized. These data suggest that
there may be important biochemical differences between the
human and mouse telomerase preparations. These differ-
ences may be in the telomerase itself or in other components
in the preparation. With the knowledge that mouse cell
extracts synthesize very short products in vitro, the identi-
fication of telomerase activity in organisms where it has not
previously been found may now be possible.
The difference in the length of the human and mouse
telomerase products could be due to a difference in the
processivity of the two enzymes. To determine whether the
long products synthesized by the human enzyme are made in
a processive or di tributive manner, a primer challenge
experiment was performed (7). A telomerase reaction was
carried out for only 3 min with human 293 cell extract and
[a-32P]dGTP. After this initial pulse with [a-32P]dGTP, part of
the sample was diluted 30-fold into a mixture containing
unlabeled dGTP and an excess of competitor (TTAGGG)3
primer and the reaction was allowed to continue for a total of
9, 18, or 36 min (Fig. 3A). The products continued to increase
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FIG. 2. Pausing pattern of mouse telomerase. The FM3A DEAE fraction was assayed for telomerase activity as in Fig. 1 with different
telomeric oligonucleotides as primers. Lanes 1 and 2, human 293 cell S-100 extract, (TTAGGG)3; lanes 3-18, FM3A DEAE fraction; lanes 3
and 4, (TTAGGG)3; lanes 5 and 6, (GGGTTA)3; lanes 7-12, (GTTAGG)3; lanes 13 and 14, (TTGGGG)3; lanes 15 and 16, (GGGGTT)3; lanes
17 and 18, (GTTGGG)3; lanes 9 and 10, 0.5 mM ddATP was used instead ofdATP; in lanes 11 and 12, 0.5 mM ddTTP was used instead ofdTTP.
The position of a 32P-labeled (TTAGGG)3 is indicated. The numbers at left and right indicate the position of the additional nucleotides added
to the input 18-mer primer. +/-, with/without RNase pretreatment.
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FIG. 3. Processivity of human and mouse telomerase. (A) Human telomerase primer-challenge experiment. S-100 extract from human 293
cells was assayed for processive telomerase activity as described in Materials and Methods. The reaction mixture was diluted after 3 min into
unlabeled dGTP with excess primer (lanes 1-3) or with no primer (lanes 4-6), and aliquots were terminated at 9, 18, and 36 min. Lane 7, undiluted
reaction mixture terminated at 36 min. Position of a 32P-labeled (TTAGGG)3 is indicated. Numbers at left indicate product length in nucleotides.
(B) Mouse telomerase primer-challenge experiment. Lane 1, 293 S-100 extract (20 dAl) was assayed as in Fig. 1 for 120 min. FM3A DEAE fraction
was assayed as described in Materials and Methods. The reaction mixture was diluted after 3 min into unlabeled dGTP with excess primer Qanes
3-6) or no primer (lanes 7-10) and terminated at 15, 30, 60, and 120 min. Lanes 2 and 11, undiluted reaction mixture terminated at 3 min and
120 min, respectively. Arrows indicate the positions of the reaction products. The position of a 32P-labeled (TTAGGG)3 is indicated. The
exposure shown is a PhosphorAutoradiograph (Fujix BAS 2000 Biolmaging Analyzer) photograph from an HG printer (Fuji).
in length after dilution into unlabeled dGTP, indicating that
the enzyme is processive in vitro.
The short products generated by mouse telomerase suggest
that the enzyme is not highly processive under the conditions
we used. To determine whether long products could be
generated under other reaction conditions, we tested a vari-
ety of salts, MgCl2 concentrations, several different temper-
atures, and the addition of either rATP or rGTP up to 10 mM,
with and without an energy-regenerating system. No long
products similar to those seen with the human enzyme were
observed (data not shown).
To test whether the mouse telomerase can act processively
to synthesize more than one repeat, a primer challenge
experiment similar to the one described above was per-
formed. The Tetrahymena primer (GTTGGG)3 was used in
the reactions, since longer products are generated with this
oligonucleotide. The telomerase reaction was initiated with
[a-32P]dGTP and then diluted into an excess of (GGGGTT)3
primer and unlabeled dGTP. The short product initially
synthesized was not chased into higher repeats after 15, 30,
60, or 120 min of total reaction time (Fig. 3B). This suggests
that the mouse telomerase is not processive. Because the low
level ofradioactive dGTP incorporated in the 3-min pulse, the
synthesis of a second repeat without dissociation cannot be
ruled out. However, it is clear from both the length of the
products and the ratio of the first repeat to the second in the
products of the human and mouse enzymes (Fig. 2, lanes 2
and 4) that the mouse telomerase is significantly less proces-
sive than the human enzyme.
The short reaction products in the mouse extracts could be
due to an inhibitor which affects the processivity of the
mouse enzyme or to a lack of a processivity factor. If an
inhibitor were present, mixing the mouse extract with the
human extract might result in the synthesis of only short
products by both enzymes. To test this, 10 .ul of human 293
cell extract was mixed with 1, 3, 5, or 10 .ul of active mouse
telomerase from the 0.2 M NaCl DEAE eluate. The ability of
the human telomerase to synthesize long products was not
inhibited by the addition ofmouse extract (Fig. 4A). Thus the
synthesis of only short products in the mouse extracts is not
due to a diffusible inhibitor in the extract. In an analogous
experiment, we tested whether there is a diffusible proces-
sivity factor in the human extracts which might stimulate the
production of long products by the mouse enzyme. Human
S-100 extract was treated with micrococcal nuclease to
destroy telomerase activity. After inactivation of the micro-
coccal nuclease with EGTA, the extract was mixed with
FM3ADEAE fraction. The addition ofthe inactivated human
extract to active FM3A telomerase had no effect on the length
of the mouse reaction products (Fig. 4B). A putative diffus-
ible processivity factor may be present in the human extracts,
but the species differences or reaction conditions used may
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FIG. 4. Mixing of human and mouse telomerase extracts. (A) Ten
microliters of 293 S-100 extract was mixed with 0 (lane 1), 1 ILI (lane
2), 3 p.1 (lane 3), 5 ,ul (lane 4), or 10 ,ul (lanes 5 and 6) of FM3A DEAE
fraction and assayed for telomerase activity as in Fig. 1. The position
of a 32P-labeled (TTAGGG)3 is indicated. +/-, with/without RNase
A pretreatment. (B) Samples of 293 S-100 extract alone (lane 4) or
treated with inactivated micrococcal nuclease (MNase, lane 3) or
active MNase (lane 1) were assayed for telomerase activity. A
portion of the sample treated with MNase was then inactivated by
addition of EGTA and mixed with fresh 293 S-100 (lane 2) or with
FM3A DEAE fraction (lanes 5 and 6). The sample in lane 5 was
pretreated with RNase A before assay for telomerase activity. Lane
7, FM3A DEAE extract alone. The position of a 32P-labeled
(TTAGGG)3 is indicated. Arrow indicates the position of the FM3A
reaction product.
have prevented stimulation of the mouse enzyme. Finally,
mixing of inactive mouse DEAE fractions (0.1, 0.3, and 0.4
M NaCl eluates) with the active 0.2 M NaCl fraction did not
result in the generation of long products by the mouse
enzyme (data not shown). If hybrid mouse-human cell lines
containing only one human chromosome are tested for the
ability to synthesize long telomerase products, it may be
possible to identify a human processivity factor and assign it
or the human telomerase to a specific chromosome.
Telomerase preparations from five different immortal hu-
man cell lines all generated long products in vitro, whereas
telomerase from four different mouse cell lines synthesized
very short products. Although this is not an exhaustive study,
it suggests that there is a species or biochemical difference in
the processivity of human and mouse telomerase enzymes.
Since Mus musculus has been characterized as having "ultra-
long telomeres" in vivo (20), it is interesting that the 'ultra-
short' telomerase products generated in vitro are derived
from this species. Human telomeres have shorter stretches of
(TTAGGG)3 than mouse (30, 31), and yet human telomerase
activity is more processive in vitro. A similar discrepancy
between the in vivo and in vitro processivity is found with
Tetrahymena telomerase (7, 8). These observations suggest
that factors other than telomerase may be involved in the in
vivo regulation of telomere length. The evidence that telo-
meres may play a role in cellular aging and immortalization
(15, 16, 18) illustrates the importance of identifying all of the
factors which regulate telomere length. The biochemical
differences between the human and mouse telomerase may
aid in the identification of factors which regulate both telo-
merase activity and telomere length. Identification of mouse
telomerase will also allow the use of transgenic mice to test
the roles of telomere length and telomerase in vivo.
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